Jun Bei Liu talks us through some rare stock picks and talks the potential US-China trade deal, we walk through the charts and talk WBC, MQG and BHP, and ask a bullion expert: why is Gen Z suddenly buying gold?
On this week's show: Burman Invest's Julia Lee, Fairmont Equities' Michael Gable, ELMO's Danny Lessem, Morgans' Raymond Chan and Switzer's Paul Rickard.
Dr Ross explains herd immunity and how it could work in the case of COVID-19.
Catch up with Peter Switzer and Paul Rickard for the latest money news locally and overseas.
Fortescue CEO Elizabeth Gaines joins this week's show, along with Burman Invest's Julia Lee, Shawn and Partners' Adam Dawes and Switzer's Paul Rickard.
Dr Ross Walker shares his criticisms about how the coronavirus pandemic has been handled.
Peter Switzer and Paul Rickard discuss masking up for the economy, rising gold prices and the looming reporting season.
On this week's show: Burman Invest's Julia Lee, Medallion's Michael Wayne, Morgans' Michael Knox and Switzer's Paul Rickard.
Dr Ross Walker examines the effectiveness of hydroxychloroquine.
Peter Switzer and Paul Rickard discuss gains in the stock market despite infection rates in Victoria and the US, the Aussie dollar moving above 71 US cents and when employees will head back to the office.
Joining Peter Switzer on this week's show: Burman Invest's Julia Lee, Shaw and Partners' Adam Dawes, FNArena's Rudi Filapek-Vandyck and Metrics Credit Partners' Andrew Lockhart.
With over 100 vaccines for COVID-19 currently being trialled, Dr Ross Walker explains what vaccination is and how the latest research into Coronavirus vaccines is progressing.
Peter Switzer is joined by the Managing Director of Rafaella Resources (RFR), Steven Turner.
Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox